title: Factors influencing the magnitude, duration, and rate of fall of B-cell function in type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis.
abstract: The pattern of fall in B-cell function measured as plasma and 24 h urinary C-peptide excretion, as well as levels of islet cell antibodies, insulin antibodies and metabolic parameters, were followed for two years in 39 children aged 1-17 years prospectively from clinical onset of Type 1 (insulin-dependent) diabetes. At onset 32/36 patients had measurable plasma C-peptide (median 0.13 nmol/l). Maximum values of fasting and postprandial plasma C-peptide were reached at a median duration of three months. Thereafter both plasma and urinary C-peptide declined linearly. The median value of the rate of fall in postprandial plasma C-peptide was 0.019 nmol.1-1.month-1. Age at onset was positively correlated to the maximum value of postprandial plasma C-peptide in each patient (rs = 0.57, p = 0.0001) and throughout the observation time positively correlated to fasting and postprandial C-peptide and to the 24 h urinary C-peptide excretion (rs range 0.35-0.70, p = 0.03-0.0001). The rate of fall of postprandial C-peptide was unrelated to age at onset and was strikingly parallel in different age groups. Islet cell antibodies were present in 87% of the patients at onset and decreased to 38% at 24 months. Islet cell antibody titres were not correlated to age at onset or to plasma or urinary C-peptide at any single observation. However, islet cell antibody negative patients had significantly higher (p less than 0.05) postprandial plasma C-peptide values at 1, 9, and 12 months of duration, compared to islet cell antibody positive patients.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Paediatrics, Karolinska Institute, St. Göran's children's Hospital, Stockholm, Sweden.
authors.forename: M
authors.initials: M
authors.lastname: Wallensteen
authors.forename: G
authors.initials: G
authors.lastname: Dahlquist
authors.forename: B
authors.initials: B
authors.lastname: Persson
authors.forename: M
authors.initials: M
authors.lastname: Landin-Olsson
authors.forename: A
authors.initials: A
authors.lastname: Lernmark
authors.forename: G
authors.initials: G
authors.lastname: Sundkvist
authors.forename: B
authors.initials: B
authors.lastname: Thalme
mesh_terms: D000293:Adolescent; D002096:C-Peptide / Q000097:blood*; D002648:Child; D002675:Child, Preschool; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000276:immunology / Q000503:physiopathology*; D004435:Eating; D005215:Fasting; D005260:Female; D005500:Follow-Up Studies; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007223:Infant; D007330:Insulin Antibodies / Q000032:analysis; D007515:Islets of Langerhans / Q000378:metabolism*; D008297:Male
chemical_list: D002096:C-Peptide; D006442:Glycated Hemoglobin; D007330:Insulin Antibodies